Urine drug testing in the treatment of chronic noncancer pain in a Kentucky private neuroscience practice: the potential effect of Medicare benefit changes in Kentucky.
Gilbert
John W
JW
Spine and Brain Neurosurgical Center, Lexington, KY, USA.
Wheeler
G R
GR
Mick
G E
GE
Storey
B B
BB
Herder
S L
SL
Richardson
G B
GB
Watts
E
E
Gyarteng-Dakwa
K
K
Marino
B S
BS
Kenney
C M
CM
Siddiqi
M
M
Broughton
P G
PG
D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007629:Kentucky; D006278:Medicare / Q000639:trends*; D009293:Opioid-Related Disorders / Q000175:diagnosis* / Q000453:epidemiology / Q000652:urine*; D018710:Pain Clinics / Q000191:economics / Q000592:standards / Q000706:statistics & numerical data*; D010148:Intractable Pain / Q000188:drug therapy*; D010342:Patient Acceptance of Health Care; D010349:Patient Compliance; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data; D011237:Predictive Value of Tests; D012051:Reimbursement Mechanisms / Q000639:trends*; D012189:Retrospective Studies; D012680:Sensitivity and Specificity; D015813:Substance Abuse Detection / Q000191:economics / Q000592:standards / Q000706:statistics & numerical data*; D014481:United States; D016482:Urinalysis / Q000592:standards / Q000706:statistics & numerical data
D000701:Analgesics, Opioid